- Perspectives in immunotherapy: Meeting report from the "Immunotherapy Bridge", Napoli, December 5th 2015. Journal for ImmunoTherapy of Cancer. 2016 Academic Article GET IT
Crizotinib versus chemotherapy in advanced ALK-positive lung cancer.
New England Journal of Medicine.
Times cited: 2150
Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: A trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organization for Research and Treatment of Cancer.
Journal of Clinical Oncology.
Times cited: 216